Animal Parasiticides Market – Expected Revenue Growth in Near Future

Overview of This Study:

The study involved four major activities for estimating the size of the animal parasiticides market. Exhaustive secondary research was done to collect information on the market, including its peer markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Expected Revenue Growth:

The global animal parasiticides market is projected to reach USD 13.7 billion by 2025 from USD 9.7 billion in 2020, at a CAGR of 7.2 % during the forecast period. Market growth can be attributed to the growing population of companion animals, rising demand for animal-derived food products, growing concerns of zoonotic diseases, rising animal pet expenditure, and increasing investments from private players.

Download PDF Brochure@

North America will continue to dominate the market during the forecast period

Geographically, the global animal parasiticides market has been segmented into five major regional segments—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2019, North America accounted for the largest share of the market in 2019, followed by Europe and the Asia Pacific. North America’s leading position is primarily due to the rising pet expenditure, the growing population of companion animals, and the increasing consumption of animal-derived food products.

Key Market Players:

The prominent players in the global Animal parasiticides market are Boehringer Ingelheim (Germany), Elanco (US), Zoetis (US), Merck (US), and Virbac (France).

Recent Developments in the Global Animal Parasiticides Market:

In February 2020, Zoetis launched Simparica Trio, a parasiticide for dogs with, or at risk from, mixed external and internal parasitic infestations.

In February 2020, Elanco signed an agreement with Merck Animal Health to divest its worldwide rights for Vecoxan, used for the prevention and treatment of coccidiosis in calves and lambs.

In February 2020, Vetoquinol acquired rights to Profendor and Drontal (parasiticides for companion animals offered by Elanco) for the European Economic Area and the UK.

In August 2019, Boehringer Ingelheim opened a Health Management Center in China.

Key Questions Addressed in the Report

Which are the top 10 players operating in the animal parasiticides market?
# What are the drivers, restraints, opportunities, and challenges impacting the market?
# What are the prevailing industry trends?
What is the current scenario of the animal parasiticides market?
How is the animal parasiticides market performing in different regions across the globe?

Request Sample Pages@

Research Methodology Followed:

Top-down and bottom-up approaches were used to validate the size of the global animal parasiticides market and dependent submarkets. Various secondary sources such as directories, industry journals, databases, and annual reports of companies have been used to identify and collect information useful for the study of this market. Primary sources such as experts from both the supply and demand sides have been interviewed to obtain and validate information as well as assess the dynamics of this market.

Target Audience:

 Veterinary hospitals and clinics
Veterinary research institutes
Animal health companies
Animal farms
Government associations
Market research and consulting firms
Venture capitalists and investors